Insulin Pump or CGM Denied by Insurance? How to Appeal

Insulin pumps and continuous glucose monitors (CGMs) are evidence-based tools that dramatically improve diabetes management, reduce A1c, cut hypoglycemic episodes, and lower long-term complication risk. Despite this evidence — and despite their inclusion in the ADA Standards of Medical Care and Medicare coverage rules — they are among the most frequently denied medical devices. This guide shows you exactly how to build a successful appeal.

Why Insurers Deny Insulin Pumps and CGMs

Type 1 diabetes documentation gap. Many plans restrict insulin pump coverage to patients with documented Type 1 diabetes. Documentation requirements vary — some plans require C-peptide testing (C-peptide ≤0.5 ng/mL is a common Medicare threshold), while others require GAD/ICA/IA-2 antibody testing. If your denial cites inadequate T1D documentation, obtain the required lab tests and include them in your appeal.

"Adequate control on MDI." The insurer argues your diabetes is adequately managed on multiple daily injections. Counter: the ADA Standards of Medical Care 2024 recommend automated insulin delivery (AID) systems as the standard of care for T1D patients, citing consistent evidence of TIR improvement of 10–15 percentage points vs. MDI, plus significant hypoglycemia reduction.

CGM denied for T2D non-insulin users. Medicare expanded CGM coverage in 2023 to cover all Medicare beneficiaries with diabetes who require frequent blood glucose testing. For commercial insurance, CGM coverage for T2D patients not using insulin requires documentation of individual clinical benefit — glucose variability, hypoglycemia, or the need for frequent monitoring.

Hypoglycemia not sufficiently documented. Most insulin pump PA criteria require documented hypoglycemic episodes or hypoglycemia unawareness. Blood glucose logs showing values below 70 mg/dL, CGM data showing time below range, or clinical documentation of hypoglycemia unawareness syndrome (HUA) are required.

Non-preferred device brand. If the plan covers one insulin pump system but not another, a formulary exception is required. Clinical arguments include: specific pump compatibility with your CGM system (integrated closed-loop); documented adverse experience with the preferred pump; or clinical features of the requested pump that are medically necessary for your management.

"Adjunctive device only" classification for CGM. Some older plan policies classify CGM as adjunctive rather than therapeutic. The FDA classifies the Dexcom G7 and FreeStyle Libre 2/3 as therapeutic — replacing fingerstick testing — and Medicare coverage policy reflects this. Use the FDA therapeutic classification to challenge this denial.

How to Appeal an Insulin Pump or CGM Denial

Step 1: Request the insurer's specific coverage criteria and CPB

Ask the insurer in writing for the Clinical Policy Bulletin (CPB) or coverage determination for insulin pumps or CGM. This document lists exactly what criteria you must meet — making it your roadmap for the appeal.

Step 2: Compile diabetes-specific documentation

For insulin pump appeals: C-peptide level documenting insulin deficiency; endocrinologist letter explaining why CSII is medically necessary over MDI; A1c history; glucose log or CGM data showing hypoglycemic episodes, glucose variability, or failure to achieve targets on MDI; and documentation of any hypoglycemia unawareness.

For CGM appeals: diabetes diagnosis and insulin use documentation; physician letter explaining why CGM is medically necessary; current fingerstick frequency or CGM data; and A1c demonstrating need for improved monitoring.

Step 3: Obtain your endocrinologist's clinical necessity letter

The letter must address the insurer's specific denial reason. For AID/pump denials: cite ADA Standards of Medical Care 2024 recommending AID systems for T1D; cite ATTD Consensus recommendations on Time in Range (TIR) targets; document hypoglycemia frequency and unawareness; explain why MDI is inadequate. For CGM: cite ADA's recommendation for CGM for all insulin-using patients; document the specific clinical benefit of real-time glucose data.

Step 4: Cite the clinical evidence base

Insulin pump evidence: DCCT trial demonstrated intensive insulin management reduces diabetic complications by 50–75%. AID systems (Omnipod 5, Tandem Control-IQ, Medtronic MiniMed 780G) show TIR improvements of 10–15 percentage points vs. MDI, and hypoglycemia reduction of 30–50%.

CGM evidence: ADA Standards 2024 recommend CGM for all patients using insulin (T1D and T2D). Randomized trials including DIAMOND and GOLD trials show A1c reductions of 0.3–0.5% and significant hypoglycemia reduction with CGM vs. fingersticks for MDI-treated patients.

Step 5: Invoke Medicare DME coverage rules if applicable

For Medicare: insulin pumps are covered under Part B as DME when: T1D or insulin-requiring T2D is documented; C-peptide criteria are met; and medical necessity is documented. CGM is covered under Part B as therapeutic DME for all Medicare beneficiaries with diabetes requiring frequent blood glucose testing.

Step 6: Submit the formal appeal and request peer-to-peer review

File the appeal with complete documentation and request your endocrinologist conduct a peer-to-peer review with the insurer's medical director. Most insulin pump and CGM denials that are medically well-supported resolve at peer-to-peer or internal appeal.

What to Include in Your Appeal

• C-peptide level and/or antibody testing results (for T1D documentation in insulin pump appeals)
• Endocrinologist letter citing ADA Standards 2024 and ATTD Consensus for AID/pump; ADA Standards for CGM
• CGM data or glucose log documenting hypoglycemia frequency, time below range, or glucose variability
• A1c history over 12–24 months demonstrating inadequate control on current regimen
• Hypoglycemia unawareness documentation if applicable (clinical notes, endocrinologist assessment)
• ADA Standards 2024 citation and ATTD Consensus supporting the specific device

Fight Back With ClaimBack

Insulin pump and CGM denials require appeals grounded in ADA Standards, ATTD Consensus guidelines, Medicare coverage rules, and documented clinical need. ClaimBack generates a professional appeal in 3 minutes. Start your free claim analysis → Free analysis · No credit card required · Takes 3 minutes

Related Reading

• How to Write an Insurance Appeal Letter
• What Is Medical Necessity?
• Internal vs External Insurance Appeal